Performance
The laboratory determines applicable performance specifications, acceptance criteria, reference information, and ongoing verification needs.
For hospitals and laboratories
Qualified hospitals and laboratories interested in MMP-7 measurement and TR-FRET technology may contact Dx4Liver for general institutional information.

TR-FRET is a homogeneous, plate-based fluorescence technology. Its potential operational characteristics include time-resolved detection, reduced background, and no-wash formats.
Any decision to investigate, implement, or use an MMP-7 method belongs within the institution’s scientific, clinical, quality, compliance, and governance processes.
Review the technology overviewCore responsibility
The laboratory determines applicable performance specifications, acceptance criteria, reference information, and ongoing verification needs.
The laboratory establishes quality-control procedures, documentation, personnel competency, instrumentation, and change control.
The institution determines intended use, clinical interpretation, reporting practices, and compliance with applicable requirements.
Laboratories are solely responsible for determining the appropriate use of any MMP-7 assay and for meeting all applicable validation, quality, accreditation, institutional, and regulatory requirements. Dx4Liver does not perform patient testing, validate assays for clinical use, establish clinical reference intervals, or interpret patient results.
Connect
Tell us your institution, role, and general area of interest. Do not include patient information, medical records, results, or specimens.
Contact Dx4Liver